Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (175)	11/10/1998 9:20:00 PM
From: Dr. John M. de Castro	Respond to of 1386

Clarifications of press releases have absolutely no impact. I've seen companies try this many times with no positive impact and sometimes a negative one. Investors are suspicious of companies that are constantly trying to put spin on the news. In any case, the release is not relevant unless you're a short term investor and from all that you've posted, I've got the definite impression that you're in for the long haul. In which case the only significant clarification of the HU-211 release will be the announcement of the signing of a partnership deal with a major pharma. Now that will get peoples attention. I agree that PARS has not done a good job, in the past, of PR. But, I can see a marked improvement. The last earnings release and the conference call were very well handled and Ariella's "cold call" is a significant indicator that the corner has been turned. There is no point in trying to correct past errors. Substantive progress on PARS programs, continued increases in lotemax and Alrex sales and a partnership agreement for HU-211 will speak much louder than any rewording of old news. John de C

To: David Israel-Rosen who wrote (175)	11/10/1998 9:34:00 PM
From: tom pope	Read Replies (1) \| Respond to of 1386

David, I have a tiny position in PARS, just initiated yesterday and Friday (4K shares), and you probably have a very big one. But I really believe that PARS' success will depend on the product, not the PR. Many successful companies pay little attention to IR or PR. How many CEO's do you know that have come up from the company's PR department? Did AGIS take its position because of the PR, or because it analyzed and made a decision re PARS' products and prospects? Best Tom